Having minimal SBIR Involvement and that sometime ago, Silver Creek is a biotechnology company pioneering a new class of Smart Growth Factor⢠(SGF) medicines designed to promote repair and regeneration of functional tissues and organs by targeting and prolonging activation of growth factor repair signaling selectively in damaged tissue. The companyâs lead program, SGF-1, is in pre-IND development with the potential to repair and regenerate tissue damaged by acute myocardial infarction (AMI), acute kidney injury (AKI), and traumatic brain injury (TBI). Silver Creek Pharmaceuticals is initially organized around development of herapies to protect or repair heart tissue following a heart attack - pioneering an entirely new category of medicines also to promote resilience and regeneration of heart cel
